Quarterly report pursuant to Section 13 or 15(d)

Related Party Agreements (Details)

v3.20.1
Related Party Agreements (Details)
 1 Months Ended 3 Months Ended
Dec. 31, 2016
USD ($)
Mar. 17, 2015
USD ($)
item
Mar. 31, 2020
USD ($)
Mar. 31, 2019
USD ($)
Management Services Agreement [Member]        
Related Party Transaction [Line Items]        
Number of period   5 years    
Annual Consulting Fee   $ 500,000    
Increase In Annual Consulting Fee   1,000,000    
Excess In Net Assets Value   100,000,000    
Costs and Expenses, Related Party     $ 125,000 $ 125,000
Fortress Biotech, Inc [Member] | Founders Agreement [Member]        
Related Party Transaction [Line Items]        
Long-term Debt, Gross   $ 2,800,000    
Issuance of Common Stock, Percentage of Outstanding Diluted Equity   2.50%    
Number of Business Days   5 days    
Voting equity, Percentage of Equity or Debt Financing   2.50%    
Cash Fee, Percentage of Annual Net Sales   4.50%    
Cash Fees, Maximum Number of Days   90 days    
Control Fees, Number of Times | item   5    
Control Fees, Monthly Net Sales   12 months    
Cash Fee, Percentage of Monthly Net Sales   4.50%    
Agreement Term   15 years    
Caribe Bioadvisors LLC [Member]        
Related Party Transaction [Line Items]        
Costs and Expenses, Related Party     28,000 24,000
Annual Advisory Service Fee $ 60,000      
Caribe Bioadvisors LLC [Member] | Equity Incentive Grants [Member]        
Related Party Transaction [Line Items]        
Costs and Expenses, Related Party     $ 13,000 $ 9,000